Results

Total Results: 1,495 records

Showing results for "harms".

661. Han (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/han.pdf
     December 26, 2012 - o Benefits and harms of communicating uncertainty in clinical practice Slide 5: Uncertainty • Main … Communicating  uncertainty in clinical evidence: ethical  problems • Patient autonomy • Benefits and harms

662. Back-Pain-Imaging Clinician (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-imaging_clinician.pdf
     April 01, 2016 - studies, which may lead to followup interventions that are not beneficial and may be associated with harms … could lead to subsequent interventions that might not be benefi- cial and that might be associated with harms

663. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ear-infection_research-protocol.pdf
     August 07, 2012 - despite recent practice guidelines and systematic reviews,6, 10, 13-19 the comparative benefits and harms … Additionally, the reviewed studies found evidence of increased side effects and harms with the use of … The harms and benefits of tympanostomy tubes for managing OME in children have been addressed by two … KQ 3: What are the differences in harms or tolerability among the different treatment options? … Harms: all reported harms for each treatment option will be included.

664. labor-dystocia-protocol-amended-160728 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/labor-dystocia_research-protocol.pdf
     July 28, 2016 - KQ 2: What are the benefits and harms of amniotomy in women in spontaneous labor? … KQ 4: What are the benefits and harms of epidural analgesia in labor, particularly in terms of the risk … 5: How does the frequency of cervical examination affect the probability of specific benefits and harms … KQ 7: For women with abnormal labor, what are the relative benefits and harms of high- vs. low-dose … Benefits and harms of breast cancer screening: a systematic review. JAMA (In press). 28.

665. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/aggression_research-protocol.pdf
     October 05, 2015 - Potential harms include increased physical harm to the patient (severe and even fatal side effects,15 … Because of safety concerns in relation to aggressive behavior, our harms outcomes are more inclusive … Also, we note that harms to staff and/or patient might come from the use of seclusion or restraints … KQ 2: Regarding harms for adult psychiatric patients in acute care settings: a. … For those with active aggression, what are the comparative harms of strategies, including seclusion

666. Disposition of Comments Report for Primary Care Management of Abnormal Uterine Bleeding (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_disposition-comments.pdf
     March 21, 2013 - These tables are not intended to provide global summary judgments of the relative benefits and harms … We have deleted the reference to dydrogesterone in the discussion on harms but have retained it when … Medical Eligibility Criteria for Contraceptive Use, 201 from CDC MMWR as a source for harms data. … which we did identify trials (or trial arms) and lastly we summarize for the class of agents the harms … of the literature and rather than attempting to group as major and minor, have described all the harms

667. Gout Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
     March 01, 2016 - In patients with acute gout, what are the benefits and harms of different pharmacological therapies? … Does effectiveness (benefits and harms) differ according to patient baseline demographic characteristics … Does effectiveness (benefits and harms) differ according to disease severity, including initial clinical … In adults with gout, what are the benefits and harms of different dietary therapies and life style measures … In patients with acute gout, what are the benefits and harms of different pharmacological therapies?

668. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0368_11-08-2010.pdf
     January 01, 2010 - mindfulness-based strategies are becoming increasingly available, the balance of efficacy and potential harms

669. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0430_04-22-2011.pdf
     January 01, 2011 - of recatheterization, prevention of urinary tract infections, improved quality of life, potential harms

670. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0440_06-01-2011.pdf
     January 01, 2011 - Harms: Earlier initiation of treatment for cancer progression that does not increase survival (thereby

671. Disposition of Comments for Treatment of Glaucoma: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_disposition-comments.pdf
     April 01, 2012 - It is the balance of the benefits and harms that needs to be better evaluated. … This would require that such harms be reported with enough detail to do so. … If the included studies were to report harms in a more systematic fashion, this might be possible. … This would require that such harms be reported with enough detail to do so. … Comparison of differential harms of medical versus surgical treatment would require that those harms

672. Treatment Strategies for Women With Coronary Artery Disease: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment-future_research.pdf
     February 01, 2013 - What are the potential harms in women of: a. PCI vs. fibrinolysis/supportive therapy with STEMI? … CABG in women with stable or unstable angina 4 What are the potential harms in women of PCI vs. … 1 What are the potential harms in women of PCI vs. fibrinolysis/supportive therapy with STEMI? … What are the potential harms in women of PCI vs. … 1 What are the potential harms in women of PCI vs. fibrinolysis/supportive therapy with STEMI?

673. Disposition of Comments for Screening of Methicillin-Resistant Staphylococcus Aureus (MRSA) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_disposition-comments.pdf
     January 01, 2010 - compared to the harms of no screening/limited screening. … This CER evaluated the harms of screening for MRSA-carriage compared to the harms of not screening … the harms of not screening, and the harms of screening limited populations compared to the harms … An evaluation of the harms of screening (without a comparison of the harms of not screening) was outside … , understanding the comparative harms of screening for MRSA carriage is important.

674. heart-failure-readmission-protocol-130611 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-transition-care_research-protocol.pdf
     June 10, 2013 - An assessment of the effectiveness and harms of transitional care interventions is needed to support … Potential harms or unintended consequences of interventions do not appear to have been widely considered … Question 5 Do transitional care interventions differ in effectiveness or harms for subgroups of patients … health outcomes (KQ 2), rather than asking about the same outcomes in a separate question devoted to harms … strength of the body of evidence to answer the KQs on the comparative effectiveness, efficacy, and harms

675. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
     September 13, 2011 - or dose reduction, which is usually based on a medical plan or a desire to avoid treatment-related harms … Question 4 What are the harms associated with hepatitis C antiviral treatment adherence interventions … of HCV • Adverse Effects ○ Paradoxical decrease in adherence ○ Increase in treatment-related harms … Treatment Adherence Interventions Adults undergoing antiviral therapy Treatment Adherence Harms … In addition, the quality assessment of adverse effects and harms data will be informed by the Methods

676. Public-Reporting-Quality-Improvement Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/public-reporting-quality-improvement_research-protocol.pdf
     August 17, 2011 - Question 2 What harms result from public reporting? B. … Harms include any negative consequence or adverse events for any members of the populations listed … Examples of harms could include: a. … These negative changes could result in harms. … Analytic framework Harms (e.g ., reduced access to services for patients or misclassification

677. Template for Reports Developed (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-updates_methods.pdf
     July 01, 2011 - Reviews are systematic reviews of existing research on the effectiveness, comparative effectiveness, and harms … topic, beyond the effectiveness of a single intervention, by comparing the relative benefits and harms … Identifying new evidence on harms warrants at least the same rigor in surveillance search as that for … searched for new studies reporting adverse events or SRs, meta-analyses and HTA reports focusing on harms … need for updating now) were based on changes in four indicators: (a) evidence on the benefits and harms

678. Evidence-based Practice Center Technical Brief Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pain-chronic_research-protocol.pdf
     July 28, 2010 - populations were studied, the detailed components of the treatment program, and the health outcomes and harms … What are the potential safety issues and harms that may be associated with an MPP? … Potential Safety Issues or Harms E. … Potential Safety Issues or Harms Study Safety Issues or Harms Assessed MPP Therapy Comparison

679. Nephropathy-Contrast-Induced Executive-2016 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive-2016.pdf
     January 01, 2016 - Key Question Key Question: What are the comparative benefits and harms of different contrast media in … How do benefits or harms of contrast media differ by patient characteristics (known risk factors such … How do benefits or harms differ by the dose of contrast medium (i.e., by volume of dose and number … How do benefits or harms of contrast media differ according to the type of preventive strategy used? … We did not find any studies that examined whether the benefits or harms of contrast media differed

680. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-diff-infections_research-protocol.pdf
     May 24, 2010 - What are the harms associated with prevention strategies? c. … Question 3: What is the comparative effectiveness and harms of different antibiotic treatments? a. … Question 4: What are the effectiveness and harms of non-antibiotic adjunctive interventions? a. … environmental cultures  Days to resolution of diarrhea (choice of faster working treatment) Harms … Treatment of false positives Increased resistance Isolation harms Prevention Patient Specific